INIS
concentration
100%
plasma
98%
patients
70%
anticoagulants
59%
heparin
59%
performance
52%
metabolites
44%
wave forms
44%
sensitivity
43%
comparative evaluations
42%
interference
38%
mass spectrometry
35%
assessments
33%
molecular weight
31%
high-performance liquid chromatography
29%
accuracy
29%
drugs
28%
validation
26%
emergencies
26%
control
25%
humans
25%
prothrombin
25%
reagents
22%
recommendations
22%
reviews
22%
resolution
22%
wavelengths
22%
laboratories
22%
interactions
21%
chromatography
18%
coagulants
14%
thromboplastin
14%
risks
13%
range
12%
liquids
11%
specificity
11%
correlations
11%
levels
10%
proteins
9%
dilution
8%
buffers
8%
therapy
8%
thrombin
7%
liver
7%
errors
7%
kidneys
7%
molecules
7%
blood
6%
urine
6%
detection
6%
Pharmacology, Toxicology and Pharmaceutical Science
Betrixaban
44%
Blood Clotting Factor 10a Inhibitor
40%
Direct Oral Anticoagulant
28%
Edoxaban
24%
Apixaban
24%
Low Molecular Weight Heparin
24%
Prothrombin
24%
Activated Protein C Resistance
22%
Thromboplastin
14%
Heparin
11%
Clotting Time
9%
Anticoagulant Agent
8%
Oral Contraceptive Agent
8%
Buffer
7%
Fondaparinux
7%
Blood Stasis
7%
Thrombin
7%
Fibrinolytic Agent
6%
Activated Protein C
5%
Rivaroxaban
5%
Keyphrases
Peri-procedural
22%
Strip Test
22%
Diagnostic Test Accuracy
22%
Minimum Interference
22%
Optimal Wavelength
22%
Clot Waveform Analysis
22%
Pharmacologically Active
22%
Indirect Factor Xa Inhibitors
11%
Spearman
8%
Protein C Activity
5%
Coagulation Kinetics
5%
Proteolysis Targeting chimera (PROTAC)
5%